At a Glance
| Magnesium Glycinate | Fadogia Agrestis | |
|---|---|---|
| Class | Supplement | Supplement |
| Common Dose (oral) | 200–350 mg | 300–600 mg |
| Total Duration | 3–6.5 hrs | 5–11 hrs |
| Routes | Oral | Oral |
Magnesium Glycinate, a Supplement, and Fadogia Agrestis, a Supplement, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Supplements, meaning they share a common pharmacological foundation. They share 2 documented effects in common, with 6 effects unique to Magnesium Glycinate and 5 unique to Fadogia Agrestis. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Magnesium Glycinate | Fadogia Agrestis | |
|---|---|---|
| Class | Supplement | Supplement |
| Common Dose (oral) | 200–350 mg | 300–600 mg |
| Total Duration | 3–6.5 hrs | 5–11 hrs |
| Routes | Oral | Oral |
| Effects |
| 8 documented |
| 7 documented |
| Level | Magnesium Glycinate | Fadogia Agrestis |
|---|---|---|
| Threshold | 50 mg | 100 mg |
| Light | 100–150 mg | 200–300 mg |
| Common | 200–350 mg | 300–600 mg |
| Strong | 350–500 mg | 600–1000 mg |
| Heavy | 500 mg | 1000 mg |
Magnesium Glycinate
Fadogia Agrestis
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.